The difference in VASH2 expression in pediatric medulloblastoma tumor tissue was not statistically significant (P > 0.05) concerning patient non-WNT/SHH type, age, whether the tumor metastasized, survival months, survival outcome, whether radiotherapy was given, and whether chemotherapy was given; the difference in VASH2 expression in pediatric medulloblastoma tissue was statistically significant (P < 0.05) concerning patient SHH type, fourth ventricle, and gender (male). This evidence concerns the gene VASH2 and medulloblastoma.